Estimations des analystes de Wall Street pour None (SRTS): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Consensus des analystes
| Achat fort | 0 |
| Achat | 6 |
| Conserver | 3 |
| Vente | 0 |
| Vente forte | 0 |
| Analystes au total | 9 |
| Note moyenne (1-5) | 0.67 |
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-05 | $-0.06 | ||
| 2026-08-13 | $-0.53 | $-0.12 | -324.0% |
| 2026-05-07 | $-0.16 | $-0.12 | -28.0% |
| 2026-02-12 | $-0.19 | $-0.06 | -245.5% |
| 2025-11-06 | $-0.06 | $-0.11 | +45.5% |
| 2025-08-07 | $-0.06 | $0.01 | -700.0% |
| 2025-05-15 | $-0.16 | $0.04 | -500.0% |
| 2025-02-05 | $0.09 | $0.10 | -10.0% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $14.8M | $20.6M | $26.4M | $27.3M | $9.6M | $27.0M | $44.5M | $24.4M | $41.8M | $27.5M |
| Coût des Ventes | $5.0M | $6.8M | $9.5M | $9.7M | $4.3M | $10.1M | $14.9M | $10.3M | $17.4M | $15.6M |
| Marge Brute | $9.8M | $13.8M | $16.9M | $17.6M | $5.2M | $17.0M | $29.6M | $14.1M | $24.4M | $11.9M |
| R&D | $1.8M | $5.5M | $6.3M | $6.4M | $4.2M | $3.4M | $3.5M | $3.7M | $4.2M | $7.8M |
| Frais Généraux | $8.4M | $12.0M | $12.7M | $13.1M | $9.3M | $9.4M | $11.3M | $10.8M | $12.1M | $14.4M |
| Charges Opérationnelles | $10.2M | $17.5M | $18.9M | $19.5M | $13.5M | $12.9M | $14.8M | $14.4M | $16.3M | $22.2M |
| Résultat Opérationnel | -$363119 | -$3.7M | -$2.0M | -$2.0M | -$8.2M | $4.1M | $14.8M | -$382000 | $8.1M | -$10.3M |
| EBITDA | $13002 | -$3.3M | -$1.2M | -$1.2M | -$6.1M | $4.7M | $28.5M | $1.1M | $9.5M | -$9.2M |
| Charges d'Intérêt | $21867 | $68881 | $156685 | 0 | $14000 | $1000 | $2000 | 0 | 0 | 0 |
| Résultat Avant Impôts | -$346448 | -$3.7M | -$2.0M | -$1.7M | -$6.8M | $4.1M | $28.0M | $652000 | $9.0M | -$9.6M |
| Impôts | 0 | 0 | 0 | 0 | 0 | 0 | $3.7M | $167000 | $2.4M | -$1.9M |
| Résultat Net | -$346448 | -$3.7M | -$2.0M | -$1.7M | -$6.8M | $4.1M | $24.2M | $485000 | $6.6M | -$7.7M |
| BPA | $-0.03 | $-0.28 | $-0.14 | $-0.07 | $-0.42 | $0.25 | $1.47 | $0.03 | $0.41 | $-0.47 |
| BPA Dilué | $-0.03 | $-0.28 | $-0.14 | $-0.07 | $-0.42 | $0.25 | $1.46 | $0.03 | $0.41 | $-0.47 |
| Actions en Circulation (Diluées) | $12.0M | $13.2M | $14.1M | $16.2M | $16.4M | $16.5M | $16.6M | $16.3M | $16.4M | $16.3M |
Prix
| Prix | $3.07 |
| Capitalisation | $51M |
Entreprises liées: BDMD · CTSO · ICCM · IPSC · KPTI · MDAI · MDCX
Plus de sections de SRTS: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions